We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+10.56%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
–
AUM
$12.2B
AUM Growth
+$1.03B
Cap. Flow
+$49.2M
Cap. Flow %
0.4%
Top 10 Hldgs %
25.44%
Holding
2,628
New
63
Increased
565
Reduced
814
Closed
130

Top Buys

Rank Stock Value
1
LQD icon
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
+$379M
2
IWM icon
iShares Russell 2000 ETF
IWM
+$14.1M
3
IJH icon
iShares Core S&P Mid-Cap ETF
IJH
+$12.6M
4
EPAM icon
EPAM Systems
EPAM
+$8.07M
5
AA icon
Alcoa
AA
+$4.54M

Top Sells

Rank Stock Value
1
EPD icon
Enterprise Products Partners
EPD
+$31.9M
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$31.2M
3
MDY icon
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
+$28.5M
4
MMP
Magellan Midstream Partners, L.P.
MMP
+$20.9M
5
AAPL icon
Apple
AAPL
+$14.5M

Sector Composition

Rank Sector Weight
1 Technology 22.34%
2 Healthcare 12.24%
3 Financials 12%
4 Consumer Discretionary 11.44%
5 Industrials 8.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CATC
1926
DELISTED
CAMBRIDGE BANCORP
CATC
$248K ﹤0.01%
2,648
– –
MGTX icon
1927
MeiraGTx Holdings
MGTX
$1.17B
$248K ﹤0.01%
10,435
– –
CVGW
1928
DELISTED
Calavo Growers
CVGW
$247K ﹤0.01%
5,820
– –
HONE
1929
DELISTED
HarborOne Bancorp
HONE
$247K ﹤0.01%
16,612
+4,093
+33% +$59.5K
RUTH
1930
DELISTED
Ruth's Hospitality Group, Inc.
RUTH
$246K ﹤0.01%
12,375
– –
FDMT icon
1931
4D Molecular Therapeutics
FDMT
$609M
$245K ﹤0.01%
11,182
+3,203
+40% +$78.5K
PMVP icon
1932
PMV Pharmaceuticals
PMVP
$65.1M
$245K ﹤0.01%
10,611
– –
HOV icon
1933
Hovnanian Enterprises
HOV
$799M
$245K ﹤0.01%
1,923
– –
BLUE
1934
DELISTED
bluebird bio
BLUE
$245K ﹤0.01%
1,225
-666
-35% -$157K
ANAB icon
1935
AnaptysBio
ANAB
$1.66B
$244K ﹤0.01%
7,034
– –
STRO icon
1936
Sutro Biopharma
STRO
$353M
$244K ﹤0.01%
1,642
– –
GSAT icon
1937
Globalstar
GSAT
$10.7B
$244K ﹤0.01%
14,026
+2,431
+21% +$53.3K
INSW icon
1938
International Seaways
INSW
$4.71B
$243K ﹤0.01%
16,560
– –
ADV icon
1939
Advantage Solutions
ADV
$423M
$243K ﹤0.01%
1,212
+374
+45% +$76.9K
MDXG icon
1940
MiMedx Group
MDXG
$612M
$243K ﹤0.01%
40,218
+13,960
+53% +$96.9K
TBPH icon
1941
Theravance Biopharma
TBPH
$878M
$241K ﹤0.01%
21,852
+15,298
+233% +$133K
PECO icon
1942
Phillips Edison & Co
PECO
$5.2B
$241K ﹤0.01%
7,305
– –
BY icon
1943
Byline Bancorp
BY
$1.78B
$241K ﹤0.01%
8,821
– –
ACRS icon
1944
Aclaris Therapeutics
ACRS
$863M
$241K ﹤0.01%
16,582
– –
INMD icon
1945
InMode
INMD
$875M
$240K ﹤0.01%
+3,400
New +$273K
ATEX icon
1946
Anterix
ATEX
$1.79B
$240K ﹤0.01%
4,083
– –
SLCA
1947
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
$240K ﹤0.01%
25,504
+8,366
+49% +$83.4K
SHOE
1948
Shoe Station Group
SHOE
$415M
$240K ﹤0.01%
6,132
-2,096
-25% -$78.8K
HSTM icon
1949
HealthStream
HSTM
$849M
$239K ﹤0.01%
9,080
– –
ETD icon
1950
Ethan Allen Interiors
ETD
$583M
$239K ﹤0.01%
9,100
– –
76 77
78
79 80

Similar funds

Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
HHII
H&H International Investment Palo Alto, California $20B AUM 9.66% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return
P
&Partners Nashville, Tennessee $20.2B AUM 19.79% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
NAM
Nissay Asset Management Tokyo, Japan $18.9B AUM 27.21% 1-Year Est. Return
MIC
Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return

MetLife Investment Management's Q4 2021 Portfolio in Review

As of Q4 2021, MetLife Investment Management held 2,628 positions worth $12.2B, up 9.2% from $11.2B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

MetLife Investment Management's Q4 2021 filing shows 63 new, 565 increased, 814 reduced and 130 closed positions. Its largest new stake was iShares iBoxx $ Investment Grade Corporate Bond ETF: 2,855,000 shares worth $378M. The largest sale was Enterprise Products Partners, an estimated $31.9M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.

  • MetLife Investment Management's largest Q4 2021 buy was iShares iBoxx $ Investment Grade Corporate Bond ETF: 2,855,000 shares worth $378M.
  • MetLife Investment Management added most to iShares Russell 2000 ETF in Q4 2021, an estimated $14.1M increase.
  • MetLife Investment Management's biggest Q4 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $31.2M.
  • MetLife Investment Management fully exited Enterprise Products Partners in Q4 2021, selling an estimated $31.9M.
  • MetLife Investment Management's ten largest holdings make up 25% of its $12.2B portfolio in Q4 2021.
  • MetLife Investment Management opened 63 new positions and closed 130 in Q4 2021.
  • MetLife Investment Management's portfolio value rose 9.2% quarter-over-quarter to $12.2B.

Based on MetLife Investment Management's 13F filing for Q4 2021, filed 15 Feb 2022.